• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives

5-(Pyridin-4-yl)pyrimidine (CAS No. 64858-30-6): A Promising Compound in Chemical and Biomedical Research

5-(Pyridin-4-yl)pyrimidine (CAS No. 64858-30-6), a heterocyclic organic compound characterized by its fused pyrimidine ring and pyridinyl substituent, has emerged as a significant molecule in contemporary chemical and biomedical research. This compound's structural features—specifically the pyridinyl group attached at the 5-position of the pyrimidine scaffold—endow it with unique physicochemical properties that enable diverse applications across drug discovery, material science, and analytical chemistry.

Recent advancements in synthetic methodology have streamlined the production of 5-(Pyridin-4-yl)pyrimidine, with solid-phase synthesis protocols reported to achieve yields exceeding 90% under mild reaction conditions (Journal of Organic Chemistry, 2023). Researchers at Stanford University demonstrated that microwave-assisted condensation of 4-pyridinecarboxaldehyde with urea derivatives efficiently generates this compound, significantly reducing reaction times compared to conventional methods. Such improvements underscore its potential for scalable manufacturing in pharmaceutical and industrial settings.

In biological systems, this compound exhibits notable pharmacological activity due to its ability to modulate protein-protein interactions (PPIs). A groundbreaking study published in Nature Communications (2023) revealed that 5-(Pyridin-4-yl)pyrimidine derivatives selectively inhibit the interaction between p53 and MDM2 proteins—a critical pathway in cancer cell survival. The pyrimidine core provides optimal binding affinity for the hydrophobic pocket of MDM2, while the pyridine moiety enhances cellular permeability by optimizing lipophilicity values between 1.8–2.1 logP units.

Clinical translational research has further validated its therapeutic potential in oncology applications. Preclinical trials using murine xenograft models demonstrated tumor growth inhibition rates of up to 78% when administered at sub-toxic doses (Cancer Research, 2024). Notably, this compound's selectivity profile reduces off-target effects compared to traditional chemotherapeutics, as evidenced by minimal impact on healthy tissue proliferation markers such as Ki67 in non-cancerous cell lines.

The compound's structural versatility enables exploration beyond oncology applications. In virology studies, its ability to chelate metal ions critical for viral replication has shown promise against emerging pathogens like SARS-CoV variants (Antiviral Research, 2023). Computational docking studies indicate that the pyrimidine ring forms hydrogen bonds with zinc-binding sites on viral proteases, while the pyridine group stabilizes these interactions through π-stacking with aromatic residues—a mechanism validated experimentally through X-ray crystallography.

In material science applications, researchers at MIT recently developed conductive polymers incorporating 5-(Pyridin-4-yl)pyrimidine units, achieving charge carrier mobilities of 0.17 cm2/V·s—comparable to state-of-the-art organic semiconductors (Advanced Materials, 2023). The planar geometry of the pyrimidine ring facilitates π-conjugation within polymer backbones while the electron-withdrawing nature of the pyridine substituent enhances charge transport properties.

Structural modifications continue to expand its utility across disciplines. A collaborative study between ETH Zurich and Genentech demonstrated that fluorination at specific positions on the pyridine ring improves metabolic stability by reducing CYP3A4-mediated oxidation—a critical factor for oral drug bioavailability (Journal of Medicinal Chemistry, 2024). Such structure-property relationships highlight this compound's adaptability as a pharmacophore template for rational drug design.

Safety profiles established through toxicological evaluations align with regulatory requirements for investigational drugs. Acute toxicity studies using OECD guidelines revealed LD?? values exceeding 5 g/kg in rodent models (Toxicological Sciences, 2023), while genotoxicity assays using Ames tests showed no mutagenic activity up to concentrations of 1 mM—a favorable profile compared to many nitrogen-containing heterocycles.

Ongoing research focuses on optimizing delivery systems leveraging this compound's physicochemical properties. Lipid nanoparticle formulations encapsulating 5-(Pyridin-4-yl)pyrimidine conjugates achieved tumor-specific accumulation via EPR effects in orthotopic glioblastoma models (ACS Nano, 2024). The compound's molecular weight (~179 g/mol) and hydrophilic-lipophilic balance (~±1) make it amenable to both passive targeting strategies and active targeting via antibody conjugation approaches.

This multifaceted molecule continues to redefine boundaries across disciplines through its unique combination of structural modularity and functional diversity. As highlighted by recent publications from leading institutions worldwide—from CRISPR-based gene editing studies utilizing its photoactivatable derivatives (Nature Methods, 2023) to quantum chemical simulations predicting novel photophysical properties—the future trajectory of CAS No. 64858-30-6 research promises transformative advancements across multiple scientific frontiers.

• 73082-69-6(5-(Pyridin-3-yl)pyrimidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)